Clinical Trial Update: A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 blinded trial evaluating effect on atrial fibrillation burden in patients with paroxysmal atrial fibrillation; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Paroxysmal Atrial Fibrillation | Phase 2 | Status: TERMINATED | Results posted: 2019-05-22